First-trimester serum analytes, biophysical tests and the association with pathological morphometry in the placenta of pregnancies with preeclampsia and fetal growth restriction
- 30 April 2011
- journal article
- Published by Elsevier BV in Placenta
- Vol. 32 (4), 333-338
- https://doi.org/10.1016/j.placenta.2011.01.016
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Predicting the risk of pre‐eclampsia between 11 and 13 weeks' gestation by combining maternal characteristics and serum analytes, PAPP‐A and free β‐hCGPrenatal Diagnosis, 2010
- Hypertensive disorders in pregnancy: screening by biophysical and biochemical markers at 11–13 weeksUltrasound in Obstetrics & Gynecology, 2010
- Placental size and the prediction of severe early‐onset intrauterine growth restriction in women with low pregnancy‐associated plasma protein‐AUltrasound in Obstetrics & Gynecology, 2009
- A stereological perspective on placental morphology in normal and complicated pregnanciesJournal of Anatomy, 2009
- First-Trimester Prediction of Hypertensive Disorders in PregnancyHypertension, 2009
- First-Trimester Maternal Serum a Disintegrin and Metalloprotease 12 (ADAM12) and Adverse Pregnancy OutcomeObstetrics & Gynecology, 2008
- First-trimester maternal serum PP13 in the risk assessment for preeclampsiaAmerican Journal of Obstetrics and Gynecology, 2008
- ADAM12s in maternal serum as a potential marker of pre‐eclampsiaPrenatal Diagnosis, 2008
- Taking Tissue Samples from the Placenta: An Illustration of Principles and StrategiesPlacenta, 2008
- A united states national reference for fetal growthObstetrics & Gynecology, 1996